Healthcare professionals
Patients
Health
plans
Provider organizations
Government
Health technology companies
Biopharma
Biopharma
Biopharma
Today’s physicians have:
Less autonomy and decision-making power
Limited time for
in-person meetings
These trends have been accelerated by, and will continue beyond, the COVID-19 pandemic.
Biopharma must align its approach to what’s most important to physicians, which often means thinking beyond clinical information.
Copay assistance and financial programs
Additional practice support for treatment fulfillment
More product samples
69%
68%
66%
Health plans and provider organizations are partnering to:
Expand their capabilities by investing in at-scale
data and analytics platforms
Design innovative ways to control costs
and improve patient health outcomes
Maximize their mutual resources
What is pharma’s entry point?
Partner on data and social determinants of health
Understand who is bearing the risk in new
business models
Collaborate on population health management progress (via value-based contracts)
Demonstrate outcomes
Pharma needs to acknowledge this transformation with dedicated teams and roles suited to health plans’ new model.
Some health plans are adding care delivery to more traditional roles like formulary management. This new model goes beyond paying for care to providing high-quality, accessible care at a lower cost and with a better experience.
Here’s how they’re accomplishing this:
Acquiring care delivery companies
Partnering with provider organizations to integrate offerings and services that address health drivers
Health systems are investing in alternative sites of care like micro-hospitals to move patient care to the right level of acuity. These settings help:
Provider organizations to lower costs and
enhance care coordination
Patients receive the same level of care but with a better experience and closer to home
Biopharma needs to align their products, services and offerings to match each health system's unique goals and capabilities:
Pursue contracts that improve care delivery across all sites of care
Build services like patient engagement programs
around products
Develop algorithms to help find undiagnosed
patients earlier
Partner on local research
(real-world evidence studies)
Top 3 areas where physicians would like pharma’s support:
Biopharma/Healthcare professionals/Patients
Health plans/Biopharma/Patients
Provider organizations/Biopharma/Patients
Provider organizations/Biopharma/Patients
Health plans/Provider organizations/Biopharma/Patients
Health plans/Provider organizations/Biopharma/Patients